3 completed, 2 unknown, 1 recruiting, 1 terminated. 7 Phase 3, 1 Phase 2.
| Phase | Trials | Status |
|---|---|---|
| Phase 3 | 7 | Completed 3, Unknown 2, Recruiting 1, Terminated 1 |
| Phase 2 | 1 | Completed 1 |
Follow Amisulpride: new trials by email Literature Review of Amisulpride trials Research Report on Amisulpride
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Sequential Treatment Approaches for Treatment-Resistant Schizophrenia [Phase 1] Clozapine, [Phase 1] Aripiprazole, [Phase 1] Amisulpride - Treatment-resistant Schizophrenia | Phase 3 | Recruiting | Shanghai Mental Health Center | 300 | 2026-09-01 | 2026-11-05 |
| Study of Intravenous Amisulpride for Prophylaxis of Post-operative Nausea and Vomiting (PONV) in Pediatric Patients Amisulpride Injection, Dexamethasone - Nausea and Vomiting, Postoperative | Phase 2 / Phase 3 | Completed | Acacia Pharma Ltd | 453 | 2024-01-18 | 2025-06-25 |
| A Comparison of the Efficacy of Amisulpride and Placebo in the Prevention of PONV in Patients at Moderate-to-high Risk of PONV. Amisulpride, Amisulpride Placebo - PONV | Phase 3 | Unknown | Qilu Pharmaceutical (Hainan) Co., Ltd. | 516 | 2023-04-29 | 2023-04-21 |
| Pharmacovigilance in Gerontopsychiatric Patients Phenobarbital, Phenytoin, Carbamazepine - Dementia, Depression | Phase 3 | Terminated | Hannover Medical School | 407 | 2015-01-01 | 2018-02-28 |
| US Phase III Study of APD421 in PONV APD421- Amisulpride for IV injection, Placebo - PONV | Phase 3 | Completed | Acacia Pharma Ltd | 364 | 2013-08-01 | 2019-02-12 |
| Clinical Trial to Evaluate the Efficacy of Treatment vs Discontinuation in a First Episode of Non-affective Psychosis Discontinuation antipsychotic treatment, Antipsychotic treatment - Psychosis Nos/Other | Phase 3 | Unknown | Fundación Pública Andaluza Progreso y Salud | 104 | 2012-11-01 | 2014-12-05 |
| Benzamide Derivates as Treatment of Clozapine-induced Hypersalivation Amisulpride, Moclobemide - Clozapine-induced Hypersalivation | Phase 3 | Completed | Beersheva Mental Health Center | 54 | 2008-11-01 | 2012-07-26 |
Postoperative Nausea and Vomiting (3) · Anxiety Disorders (1) · Dementia (1) · Depression (1) · Psychophysiologic Disorders (1) · Schizophrenia (1) · Schizophrenia, Treatment-Resistant (1)
Acacia Pharma Ltd (2) · Beersheva Mental Health Center (1) · Fundación Pública Andaluza Progreso y Salud (1) · Hannover Medical School (1) · Qilu Pharmaceutical (Hainan) Co., Ltd. (1) · Shanghai Mental Health Center (1)
Germany (2) · United States (2) · Canada (1) · China (1) · France (1) · Israel (1) · Spain (1)
Alexander Grinshpoon, MD (1) · Anatoly Kreinin, MD, PhD (1) · Chanoch Miodownik, MD (1) · DengTang Liu (1) · Diana Shestakova, MD (1) · Helge Frieling, Prof., MD (1) · Igor Libov (1) · Kumar Belani, MD (1) · Miguel Ruiz Veguilla, MD, PhD (1) · Tong J Gan, MD (1) · Vladimir Lerner, MD, PhD (1)